US Stock MarketDetailed Quotes

PSTX Poseida Therapeutics

Watchlist
  • 3.950
  • +0.340+9.42%
Close Jul 26 16:00 ET
  • 3.940
  • -0.010-0.25%
Post 20:01 ET
382.98MMarket Cap-3376P/E (TTM)

Poseida Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Poseida Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

28.14M

+172.09%
EPS(YoY)

-0.25

+44.44%
Analyst Rating

Strong Buy

Jun 30, 2024

Poseida Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 15.417M--
--2024/Q2-- / 15.417M--
--2024/Q128.142M / 11.667M--
--2023/Q424.995M / 6.650M--
--2023/Q39.352M / 18.867M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 15.417M--
--2024/Q2-- / 15.417M--
--2024/Q128.142M / 11.667M--
--2023/Q424.995M / 6.650M--
--2023/Q39.352M / 18.867M--

Unlock Free Earnings Estimates

Poseida Therapeutics Earnings Reports

  • Poseida Therapeutics | 10-Q: Quarterly report

    May 14 16:20 ET

  • Poseida Therapeutics | 10-K: Annual report

    Mar 7 22:16 ET

  • Poseida Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 16:11 ET

  • Poseida Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg